M&A Corner
Diana Health Secures $34M to Expand Maternity Care Model10 Oct 2023
Women’s health startup Diana Health has raised $34 million in a Series B funding round led by Norwest Venture Partners.... Continue Reading
|
7wireVentures Launches $217M Growth & Opportunity Fund to Support Later-Stage Digital Health Investments10 Oct 2023
7wireVentures, a digital health venture capital firm, has successfully closed a $217 million Growth & Opportunity “GO” Fund, its largest... Continue Reading
|
Veradigm Invests $30M in Behavioral Health Co. Holmusk10 Oct 2023
Veradigm Inc. has made a $30 million strategic investment in Holmusk, a global behavioral health real-world evidence company. This collaboration... Continue Reading
|
GENZEVA and RYLTI Partner to Develop a Groundbreaking Application to More Clearly Understand the Molecular Mechanisms of Disease10 Oct 2023
Genzeva, a molecular genetic laboratory, has partnered with RYLTI to develop an innovative application of AI Knowledge Engineering and a... Continue Reading
|
Bayer to Partner with Twist Bioscience to Accelerate Drug Discovery10 Oct 2023
Bayer has entered an antibody discovery, option, and license agreement with Twist Bioscience. Twist’s “Library of Libraries” offers synthetic antibody... Continue Reading
|
65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Singapore10 Oct 2023
Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, and the Polaris Innovation Fund have partnered with Evotec SE to launch... Continue Reading
|
Medable & Pluto Health Partner to Increase Patient Access to Clinical Trials10 Oct 2023
Medable, a clinical trial technology provider, has formed an enterprise partnership with Pluto Health, a smart care coordination services company.... Continue Reading
|
New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics10 Oct 2023
New York Blood Center Enterprises (NYBCe) has acquired cell and gene therapy development and manufacturing facilities, along with technologies and... Continue Reading
|
Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase10 Oct 2023
Eli Lilly is set to acquire Point Biopharma, a Pennsylvania-based radiopharma company, in a $1.4 billion deal aimed at bolstering... Continue Reading
|
Cadence Announces the Acquisition of ARC Group Worldwide’s Florida Location10 Oct 2023
Cadence, Inc., a prominent provider of design, development, and contract manufacturing services for the medical device, drug delivery, and diagnostics... Continue Reading
|